Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Swiss (SMI) Pharma Industry Analysis

UpdatedMay 09, 2025
DataAggregated Company Financials
Companies9
  • 7D-2.6%
  • 3M-8.9%
  • 1Y10.0%
  • YTD1.2%

Over the last 7 days, the Pharma industry has dropped 1.3%, driven by Roche Holding declining 3.5%. This takes the industry's 12 month performance to a gain of 12%. As for the next few years, earnings are expected to grow by 12% per annum.

Industry Valuation and Performance

Has the Swiss Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 09 May 2025CHF 430.4bCHF 119.5bCHF 19.3b25x22.3x3.6x
Sun, 06 Apr 2025CHF 421.7bCHF 120.3bCHF 19.0b25.2x22.2x3.5x
Tue, 04 Mar 2025CHF 486.4bCHF 122.3bCHF 19.1b23.7x25.5x4x
Thu, 30 Jan 2025CHF 462.4bCHF 119.5bCHF 21.4b19.3x21.6x3.9x
Sat, 28 Dec 2024CHF 425.4bCHF 119.1bCHF 21.3b17.9x19.9x3.6x
Mon, 25 Nov 2024CHF 434.5bCHF 118.6bCHF 21.3b18.4x20.4x3.7x
Wed, 23 Oct 2024CHF 459.3bCHF 115.9bCHF 19.5b21.7x23.6x4x
Fri, 20 Sep 2024CHF 452.9bCHF 114.7bCHF 19.3b21.7x23.5x3.9x
Sun, 18 Aug 2024CHF 467.7bCHF 115.9bCHF 19.5b22.1x24x4x
Tue, 16 Jul 2024CHF 448.0bCHF 116.2bCHF 19.7b34.2x22.7x3.9x
Thu, 13 Jun 2024CHF 422.8bCHF 116.2bCHF 19.7b44.4x21.4x3.6x
Sat, 11 May 2024CHF 405.5bCHF 113.2bCHF 19.9b40.9x20.4x3.6x
Mon, 08 Apr 2024CHF 395.4bCHF 112.0bCHF 19.4b37.1x20.4x3.5x
Wed, 06 Mar 2024CHF 389.8bCHF 110.5bCHF 19.7b24.5x19.8x3.5x
Fri, 02 Feb 2024CHF 397.1bCHF 113.3bCHF 19.1b25.2x20.8x3.5x
Sun, 31 Dec 2023CHF 394.8bCHF 118.7bCHF 18.6b25.4x21.3x3.3x
Tue, 28 Nov 2023CHF 390.1bCHF 121.3bCHF 18.9b24.6x20.6x3.2x
Thu, 26 Oct 2023CHF 390.3bCHF 116.6bCHF 18.4b26.6x21.3x3.3x
Sat, 23 Sep 2023CHF 402.8bCHF 113.2bCHF 18.1b45.4x22.2x3.6x
Mon, 21 Aug 2023CHF 401.9bCHF 111.9bCHF 17.9b47.2x22.4x3.6x
Wed, 19 Jul 2023CHF 415.3bCHF 113.2bCHF 18.6b38x22.3x3.7x
Fri, 16 Jun 2023CHF 423.7bCHF 115.0bCHF 18.9b38.3x22.5x3.7x
Sun, 14 May 2023CHF 436.6bCHF 115.3bCHF 18.9b40.5x23.1x3.8x
Tue, 11 Apr 2023CHF 431.3bCHF 115.2bCHF 18.9b42.4x22.8x3.7x
Thu, 09 Mar 2023CHF 392.5bCHF 117.0bCHF 19.1b26.7x20.5x3.4x
Sat, 04 Feb 2023CHF 429.0bCHF 117.9bCHF 21.3b28.7x20.2x3.6x
Mon, 02 Jan 2023CHF 431.6bCHF 117.1bCHF 34.6b22.5x12.5x3.7x
Wed, 30 Nov 2022CHF 446.0bCHF 118.5bCHF 35.2b22.9x12.7x3.8x
Fri, 28 Oct 2022CHF 449.9bCHF 120.5bCHF 36.0b21.9x12.5x3.7x
Sun, 25 Sep 2022CHF 428.8bCHF 120.6bCHF 37.0b20.2x11.6x3.6x
Tue, 23 Aug 2022CHF 456.8bCHF 119.8bCHF 36.7b21.6x12.5x3.8x
Thu, 21 Jul 2022CHF 461.4bCHF 119.1bCHF 36.4b28.1x12.7x3.9x
Sat, 18 Jun 2022CHF 430.9bCHF 119.2bCHF 37.6b25.1x11.5x3.6x
Mon, 16 May 2022CHF 462.1bCHF 120.8bCHF 38.3b27.7x12.1x3.8x
Price to Earnings Ratio

12.1x


Total Market Cap: CHF 462.1bTotal Earnings: CHF 38.3bTotal Revenue: CHF 120.8bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Pharma Industry Price to Earnings3Y Average 19.6x202320242025
Current Industry PE
  • Investors are optimistic on the Swiss Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 22.7x which is higher than its 3-year average PE of 19.6x.
  • The industry is trading close to its 3-year average PS ratio of 3.7x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have declined 21% per year over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Swiss Healthcare industry?

CH Market0.13%
Healthcare-2.05%
Pharma-2.61%
Pharma-2.61%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
SDZ Sandoz GroupCHF 37.264.1%
+CHF 637.4m		18.3%PS1.9x
GALD Galderma GroupCHF 98.352.6%
+CHF 581.6m		38.3%PE121.6x
COPN Cosmo PharmaceuticalsCHF 49.654.2%
+CHF 32.0m		-30.1%PE6.4x
DESN Dottikon ES HoldingCHF 199.001.1%
+CHF 30.4m		-21.5%PE36.4x
NWRN Newron PharmaceuticalsCHF 8.0212.0%
+CHF 17.2m		-18.2%PE10.8x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

BIOV

CHF 33.60

BioVersys

7D

-3.7%

1Y

n/a

NOVN

CHF 91.11

Novartis

7D

-2.9%

1Y

0.6%

Novartis' (VTX:NOVN) Performance Is Even Better Than Its Earnings Suggest

May 07
Novartis' (VTX:NOVN) Performance Is Even Better Than Its Earnings Suggest

NWRN

CHF 8.02

Newron Pharmaceuticals

7D

12.0%

1Y

-18.2%

ADXN

CHF 0.056

Addex Therapeutics

7D

-6.4%

1Y

-23.7%

COPN

CHF 49.65

Cosmo Pharmaceuticals

7D

4.2%

1Y

-30.1%

SDZ

CHF 37.26

Sandoz Group

7D

4.1%

1Y

18.3%

GALD

CHF 98.35

Galderma Group

7D

2.6%

1Y

38.3%

ROG

CHF 259.90

Roche Holding

7D

-3.5%

1Y

16.9%

CURN

CHF 10.55

Curatis Holding

7D

4.5%

1Y

25.1%

DESN

CHF 199.00

Dottikon ES Holding

7D

1.1%

1Y

-21.5%

Dottikon ES Holding AG's (VTX:DESN) Business Is Yet to Catch Up With Its Share Price

Feb 12
Dottikon ES Holding AG's (VTX:DESN) Business Is Yet to Catch Up With Its Share Price